Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Masatsune, Ogura"'
Publikováno v:
AACE Clinical Case Reports, Vol 10, Iss 5, Pp 216-217 (2024)
Externí odkaz:
https://doaj.org/article/1b9106f308ca4a2680461c3a5ea91385
Autor:
Sayaka Funabashi, Yu Kataoka, Mika Hori, Masatsune Ogura, Takahito Doi, Yoshiaki Morita, Eri Kiyoshige, Kunihiro Nishimura, Teruo Noguchi, Mariko Harada‐Shiba
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
Background The atherogenic characteristics of heterozygous familial hypercholesterolemia (HeFH) increase the risk of premature atherosclerotic cardiovascular disease including not only coronary artery disease but ischemic stroke. Asymptomatic intracr
Externí odkaz:
https://doaj.org/article/5ff075290af440fdbd969ffd83c464e8
Publikováno v:
Practical Laboratory Medicine, Vol 38, Iss , Pp e00346- (2024)
Objectives: High-performance liquid chromatography (HPLC) is commonly used to measure hemoglobin A1c (HbA1c) levels and detect hemoglobin variants (Hb-Vars). HLC-723GR01 (GR01) is a new-generation automated ion-exchange HPLC system with two switchabl
Externí odkaz:
https://doaj.org/article/6434db5549f841568499e67abe4de6d4
Autor:
Masatsune Ogura
Publikováno v:
Journal of Pharmacological Sciences, Vol 150, Iss 2, Pp 81-89 (2022)
Homozygotes for loss-of-function mutations in ABCA1 cause Tangier disease. The phenotype of their markedly reduced or loss of blood high-density lipoprotein (HDL) cholesterol, as well as examination of ATP-binding cassette transporter A1 (ABCA1)-defi
Externí odkaz:
https://doaj.org/article/78ac949d62c541238685335b80cd8884
Autor:
Sayaka Funabashi, MD, Yu Kataoka, MD, PhD, Mika Hori, PhD, Masatsune Ogura, MD, PhD, Yuriko Nakaoku, MD, PhD, Kunihiro Nishimura, MD, PhD, Takahito Doi, MD, PhD, Ryo Nishikawa, MD, Kosuke Tsuda, MD, Teruo Noguchi, MD, PhD, Mariko Harada-Shiba, MD, PhD
Publikováno v:
JACC: Asia, Vol 1, Iss 2, Pp 245-255 (2021)
Background: The International Atherosclerosis Society (IAS) has proposed “severe familial hypercholesterolemia” (FH) as a phenotype with the highest cardiovascular risk. However, whether this criteria could appropriately stratify a high-risk Japa
Externí odkaz:
https://doaj.org/article/919678c5992f4a909f394bdd76e7ac22
Autor:
Sayaka Funabashi, Yu Kataoka, Mika Hori, Masatsune Ogura, Takahito Doi, Teruo Noguchi, Mariko Harada‐Shiba
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 16 (2022)
Background Heterozygous familial hypercholesterolemia (HeFH) more likely exhibits extensive atherosclerotic disease at multiple vascular beds. Lipoprotein(a) (Lp(a)) is an atherogenic lipoprotein that elevates HeFH‐related atherosclerotic cardiovas
Externí odkaz:
https://doaj.org/article/692fe8f6541d47f9afc71ce1c8560f95
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-5 (2020)
Abstract Background We previously identified the c.344G > A: p.(Arg115His) variant in the low-density lipoprotein receptor (LDLR) gene, which was interpreted as “conflicting interpretations of pathogenicity” in ClinVar, based on a genetic analysi
Externí odkaz:
https://doaj.org/article/f882df5c9c6e461db4b0df137fb7393b
Autor:
Naoto Kuyama, Yu Kataoka, Misa Takegami, Kunihiro Nishimura, Mariko Harada‐Shiba, Mika Hori, Masatsune Ogura, Fumiyuki Otsuka, Yasuhide Asaumi, Teruo Noguchi, Kenichi Tsujita, Satoshi Yasuda
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 11 (2021)
Background Statin‐mediated efficacy of lowering low‐density lipoprotein (LDL) cholesterol varies in each individual, and its diminished response is associated with worse outcomes. However, there is no established approach to predict hyporesponse
Externí odkaz:
https://doaj.org/article/74fedaa5ab9f4a999ab411678695895e
Autor:
Takahito Doi, Mika Hori, Mariko Harada‐Shiba, Yu Kataoka, Daisuke Onozuka, Kunihiro Nishimura, Ryo Nishikawa, Kosuke Tsuda, Masatsune Ogura, Cheol Son, Yoshihiro Miyamoto, Teruo Noguchi, Hiroaki Shimokawa, Satoshi Yasuda
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 4 (2021)
Background Patients with familial hypercholesterolemia who harbored both low‐density lipoprotein receptor (LDLR) and PCSK9 (proprotein convertase subtilisin/kexin type 9) gene variants exhibit severe phenotype associated with substantially high lev
Externí odkaz:
https://doaj.org/article/c77de6614ae846d88b2304ef6b00f711
Autor:
Erika, Matsumoto, Kentaro, Oniki, Ami, Ota-Kontani, Yuri, Seguchi, Yuki, Sakamoto, Tetsuya, Kaneko, Tadashi, Imafuku, Hitoshi, Maeda, Hiroshi, Watanabe, Toru, Maruyama, Yasuhiro, Ogata, Minoru, Yoshida, Mariko, Harada-Shiba, Junji, Saruwatari, Masatsune, Ogura
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 30:23-38
High levels of high-density lipoprotein cholesterol (HDL-C) are not necessarily effective in preventing atherosclerotic cardiovascular disease, and cholesterol efflux capacity (CEC) has attracted attention regarding HDL functionality. We aimed to elu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a2c6bf569733abed90751d734d7cd6
https://doi.org/10.5551/jat.63277
https://doi.org/10.5551/jat.63277